One can refer to post above by Dane Swan:
"FY21 product development costs in Cash flow Q4 YTD $321k, produced $3.983m revenue
Fy22 product development costs in Cash flow Q4 YTD at $910k, annual report $1.204m produced $9m in revenue
FY23 product development costs in cash flow Q2 YTD, $1.153, would estimate $8-$9m, split over Q2 & Q3, as $210k these costs are in Q1."
Product development costs increasing as business grows revenue but actual cash receipts are driving negative OPCF and declining bank balance - this is the financial reality requiring management action rather than omission.
Should have been addressed a long time ago and managed (with earlier preemptive raise?).
Now business has no wriggle room...if cash receipts don't dramatically improve...cost of denial will be sub 10c raise...
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
One can refer to post above by Dane Swan:"FY21 product...
-
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 3DP (ASX) to my watchlist
|
|||||
Last
5.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.49M |
Open | High | Low | Value | Volume |
5.9¢ | 5.9¢ | 5.8¢ | $5.912K | 101.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13051 | 5.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.0¢ | 250000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13051 | 0.059 |
4 | 358446 | 0.058 |
5 | 79011 | 0.057 |
2 | 553500 | 0.056 |
1 | 20000 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.060 | 250000 | 1 |
0.062 | 30144 | 2 |
0.064 | 202702 | 2 |
0.065 | 212017 | 6 |
0.066 | 159354 | 3 |
Last trade - 12.19pm 06/09/2024 (20 minute delay) ? |
Featured News
3DP (ASX) Chart |